Drug comparisons
Linagliptin vs Ertugliflozin
Linagliptin vs Ertugliflozin: DPP-4 vs SGLT2 inhibitors for T2D. Compare efficacy, CV/renal benefits, side effects & which is better.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting between DPP-4 and SGLT2 inhibitors for type 2 diabetes, particularly with cardiovascular, renal, or weight management considerations.
Bottom line
Ertugliflozin often edges out for added cardio-renal benefits, but Linagliptin may be preferable in certain renal or infection-risk scenarios.
All medication comparisons